{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001506251","name":"Citius Pharmaceuticals, Inc.","summary":"Citius Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Cranford, New Jersey, focused on developing and commercializing critical care products in oncology and anti-infectives. Its majority-owned subsidiary Citius Oncology launched LYMPHIR (denileukin diftitox-cdxl) in December 2025 for persistent or recurrent cutaneous T-cell lymphoma. Pipeline products include Mino-Lok (catheter infection treatment), Halo-Lido (hemorrhoid topical formulation), and NoveCite (mesenchymal stem cell therapy for ARDS).","people":[],"products":[{"name":"LYMPHIR (denileukin diftitox-cdxl)","type":"service","description":"FDA-approved engineered IL-2 diphtheria toxin fusion protein for treatment of persistent or recurrent cutaneous T-cell lymphoma (CTCL)."},{"name":"Mino-Lok","type":"service","description":"Antibiotic lock solution designed to treat catheter-related bloodstream infections by salvaging the infected catheter."},{"name":"Halo-Lido","type":"service","description":"Corticosteroid-lidocaine topical formulation providing anti-inflammatory and anesthetic relief for hemorrhoids."},{"name":"NoveCite","type":"service","description":"Proprietary mesenchymal stem cell therapy in development for treatment of acute respiratory distress syndrome (ARDS)."}],"partnerships":[{"partner_name":"Eisai Co., Ltd.","partnership_type":"licensing","description":"Eisai assigned all rights to E7777 (denileukin diftitox) to Citius Pharma as part of the LYMPHIR asset acquisition.","start_date":null},{"partner_name":"Dr. Reddys Laboratories SA","partnership_type":"licensing","description":"Citius acquired Dr. Reddys exclusive license of E7777 via an asset purchase agreement announced in September 2021.","start_date":null},{"partner_name":"TenX Keane Acquisition","partnership_type":"strategic","description":"Merger agreement resulting in SpinCo merging with TenX Merger Sub, forming Citius Oncology, Inc. (Nasdaq: CTOR).","start_date":null}],"affiliations":[],"origin":{"leaf":"3d3ca9e2584d0ff2774041d2c7a6867e51a0db8f8b2795bcd23908acae9dd43d","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"48ca33645fd9b6b28dbbcdf1871726006c77867ee9dc17551ddc5ed09c2358f9","parent":"a016af267e87fab5d9eeadce2d306050fa732704cc0e036fbad86f254657a076","source":"0001213900-25-125333","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":8,"hourly_limit":500,"remaining":492,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}